宫颈癌高剂量率三维近距离治疗计划设计

doi:10.3760/cma.j.issn.1004-4221.2018.05.019

摘要
图/表
参考文献()
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要

治疗计划的制定是宫颈癌三维近距离治疗关键步骤之一。通过对40余篇有关宫颈癌高剂量率近距离治疗计划设计相关文献阅读,总结归纳了三维近距离治疗计划制定原则和方法。三维近距离治疗难点较多,涉及到不同情况下的肿瘤和正常组织之间的剂量平衡,需要综合考虑各方面因素。另外,三维近距离治疗计划设计中还有一些不确定因素,未来需进一步探索和研究。希望能给从事宫颈癌三维近距离治疗同仁提供一些借鉴。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	赵红福
	程光惠
	韩东梅

关键词 ：宫颈肿瘤/近距离疗法, 高剂量率, 三维治疗计划

Abstract：

The development of a treatment plan is one of the critical steps in the three-dimensional (3D) brachytherapy for cervical cancer. This article reviews more than 40 papers on the treatment plan design of high-dose-rate brachytherapy for cervical cancer and summarizes the principles and methods for developing a treatment plan of 3D brachytherapy. There are many difficult points in 3D brachytherapy. The doses delivered to tumor and normal tissues need to be balanced by considering many different factors under different conditions. In addition, there are still some uncertain factors for developing the treatment plan of 3D brachytherapy, which needs further exploration and research in the future. It can provide some references for colleagues in 3D brachytherapy for cervical cancer.

Key words： Cervical cancer High dose rate Treatment planning

收稿日期: 2017-10-30

基金资助:

国家自然科学基金项目(31600679);吉林省科技厅社发处项目(20090458);吉林省卫生计生委项目(2014ZC054);吉林省科技厅自然基金(白求恩专项)项目(20160101079JC);吉林大学横向课题(2015373)

通讯作者: 程光惠,Email:chengguanghuifl@163.com

引用本文:

赵红福,程光惠,韩东梅. 宫颈癌高剂量率三维近距离治疗计划设计[J]. 中华放射肿瘤学杂志, 2018, 27(5): 527-532.

Zhao Hongfu,Cheng Guanghui,Han Dongmei. Treatment plan design of three-dimensional high-dose-rate brachytherapy for cervical cancer[J]. Chinese Journal of Radiation Oncology, 2018, 27(5): 527-532.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2018.05.019 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2018/V27/I5/527

[1]Henschke UK,Hilaris BS,Mahan GD.Intracavitary radiation therapy of cancer of the uterine cervix by remote afterloading with cycling sources[J].Am J Roentgenol Radium Ther Nucl Med,1966,96(1):45-51.DOI:10.2214/ajr.96.1.45.
[2]O′Connell D,Howard N,Joslin CA,et al. A new remotely controlled unit for the treatment of uterine carcinoma[J].Lancet,1965,2(7412):570-571.DOI:10.1016/S0140-6736(65)90871-8.
[3]赵红福、韩东梅、程光惠等.宫颈癌三维适形近距离治疗腔内联合插植施源器对比研究[J].中华放射肿瘤学杂志,2016,25(4):362-366.DOI:10.3760/cma.j.issn.1004-4221.2016.04.012.
Zhao HF,Han DM,Cheng GH,et al. A comparative study of Utrecht interstitial applicator and ring interstitial applicator in three-dimensional conformal brachytherapy for cervical cancer[J].Chin J Radiat Oncol,2016,25(4):362-366.DOI:10.3760/cma.j.issn.1004-4221.2016.04.012.
[4]Nomden CN,de Leeuw AAC,Moerland MA,et al. Clinical use of the utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer[J].Int J Radiat Oncol Biol Phys,2012,82(4):1424-1430.DOI:10.1016/j.ijrobp.2011.04.044.
[5]Tan PW,Koh VY,Tang JI.Outpatient combined intracavitary and interstitial cervical brachytherapy:barriers and solutions to implementation of a successful programme–a single institutional experience[J].J Contemp Brachyther,2015,7(3):259.DOI:10.5114/jcb.2015.52625.
[6]Weitmann HD,Knocke TH,Waldhäusl C,et al. Ultrasound-guided interstitial brachytherapy in the treatment of advanced vaginal recurrences from cervical and endometrial carcinoma[J].Strahlenther Onkol,2006,182:86-95.DOI:10.1007-s00066-006-1420-4.
[7]Sharma DN,Rath GK,Thulkar S,et al. Use of transrectal ultrasound for high dose rate interstitial brachytherapy for patients of carcinoma of uterine cervix[J].J Gynecol Oncol,2010,21:12-17.DOI:10.3802/jgo.2010.21.1.12.
[8]Lim KH,Lu JJ,Wynne CJ,et al. A study of complications arising from different methods of anesthesia used in high-dose-rate brachytherapy for cervical cancer[J].Am J Clin Oncol,2004,27(5):449-451.DOI:10.1097/01.coc.0000128723.00352.ad.
[9]Chen HC,Leung SW,Wang CJ,et al. Local vaginal anesthesia during high-dose-rate intracavitary brachytherapy for cervical cancer[J].Int J Radiat Oncol Biol Phys,1998,42(3):541-544.DOI:10.1016/S0360-3016(98)00243-0.
[10]Petric P,Mohammed-Al-Hammadi N.MRI findings at image guided adaptive cervix cancer brachytherapy:radiation oncologist′s perspective[J].J Contemp Brachyther,2014,6(2):215-222.DOI:10.5114/jcb.2014.43459.
[11]Koom WS,Sohn DK,Kim JY,et al. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer:preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy[J].Int J Radiati Oncol Biol Phys,2007,68(5):1446-1454.DOI:10.1016/j.ijrobp.2007.02.009.
[12]Haie-Meder C,Potter R,Van Limbergen E,et al. Recommendations from gynecological (GYN) GEC-ESTRO working group (I):Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV[J].Radiother Oncol,2005,74(3):235-245.DOI:10.1016/j.radonc.2004.11.005.
[13]Dimopoulos JC,Petrow P,Tanderup K,et al. Recommendations from gynecological (GYN) GEC-ESTRO working group (IV):basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy[J].Radiother Oncol,2012,103(1):113-122.DOI:10.1016/j.radonc.2011.12.024.
[14]Han K,Milosevic M,Fyles A,et al. Trends in the utilization of brachytherapy in cervical cancer in the United States[J].Int J Radiat Oncol Biol Phys,2013,87(1):111-9.DOI:10.1016/j.ijrobp.2013.05.033.
[15]Barraclough LH,Swindell R,Livsey JE,et al. External beam boost for cancer of the cervix uteri when intracavitary therapy cannot be performed[J].Int J Radiat Oncol Biol Phys,2008,71(3):772-778.DOI:10.1016/j.ijrobp.2007.10.066.
[16]Gerbaulet A.The GEC ESTRO handbook of brachytherapy[M].Leuven:ACCO,2002.
[17]Mazeron R,Castelnau-Marchand P,Dumas I,et al. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy[J].Radiother Oncol,2015,114(2):257-263.DOI:10.1016/j.radonc.2014.11.045.
[18]Georg,P.Kirisits,C,??,et al.Correlation of dose-volume parameters,endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy[J].Radiother. Oncol.2009,91(2):173-180.DOI:10.1016/j.radonc.2009.01.006.
[19]Tan,Y,Choo IBA,Lee KM.2D to 3D evaluation of organs at risk doses in intracavitary brachytherapy for cervical cancer[J].J Contempor Brachyther,2010,2(1):37-43.DOI:10.5114/jcb.2010.13721.
[20]Lindegaard JC,Fokdal LU,Nielsen SK,et al. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective[J].Acta Oncol.2013,52(7):1510-1519.DOI:10.3109/0284186X.2013.818253.
[21]Potter R,Georg P,Dimopoulos JC,et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer[J].Radiother Oncol,2011,100(1):116–123.DOI:10.1016/j.radonc.2011.07.012.
[22]Logsdon MD,Eifel PJ.FIGO ⅢB squamous cell carcinoma of the cervix:an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy[J].Int J Radiati Oncol Biol Phys,1999,43(4):763.DOI:10.1016/S0360-3016(98)00482-9.
[23]Bentzen SM,Dörr W,Gahbauer R,et al. Bioeffect modeling and equieffective dose concepts in radiation oncology – Terminology,quantities and units[J].Radiother Oncol,2012,105(2):266-268.DOI:10.1016/j.radonc.2012.10.006.
[24]Beadle BM,Jhingran A,Salehpour M,et al. Cervix regression and motion during the course of external beam chemoradiation for cervical cancer[J].Int J Radiat Oncol Biol Phys,2009,73(1):235-241.DOI:10.1016/j.ijrobp.2008.03.064.
[25]Lim K,Chan P,Dinniwell R,et al. Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy:radiobiologic modeling and correlation with tumor hypoxia.[J].Int J Radiat Oncol Biol Phys,2008,70(1):126-133.DOI:10.1016/j.ijrobp.2007.06.033.
[26]Potter R,Haie-Meder C,Van Limbergen E,et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (Ⅱ):Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy,radiation physics,radiobiology[J].Radiother Oncol.2006,78(1):67-77.DOI:10.1016/j.radonc.2005.11.014.
[27]Tanderup K,Hellebust TP,Lang S,et al. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer[J].Radiother Oncol,2008,89(2):156.DOI:10.1016/j.radonc.2008.06.010.
[28]Hellebust TP,Kirisits C,Berger D,et al. Recommendations from gynecological (GYN) GEC-ESTRO working group:Considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy[J].Radiother Oncol,2010,96(2):153-160.DOI:10.1016/j.radonc.2010.06.004.
[29]Hellebust TP,Tanderup K,Bergstrand ES,et al. Reconstruction of a ring applicator using CT imaging:impact of the reconstruction method and applicator orientation[J].Phys Med. Biol,2007,52(16):4893-4904.DOI:10.1088/0031-9155/52/16/012.
[30]Tanderup K,Nielsen SK,Nyvang GB,et al. From point A to the sculpted pear:MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer[J].Radiother Oncol,2010,94:173-180.DOI:10.1016/j.radonc.2010.01.001.
[31]Kirisits C,Lang S,Dimopoulos J,et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer:design,application,treatment planning,and dosimetric results[J].Int J Radiat Oncol Biol Phys,2006,65(2):624-630.DOI:10.1016/j.ijrobp.2006.01.036.
[32]Deepinder PS,Kevin CB.Ahmad M,et al. Is there a subset of patients with recurrent cancer in the vagina who are not candidates for interstitial brachytherapy that can be treated with multichannel vaginal brachytherapy using graphic optimization?[J].J Contemp Brachyther,2015,7(2):135-141.DOI:10.5114/jcb.2015.51231.
[33]Jamema SV,Kirists C,Mahantshetty U,et al. Comparision of DVH parameters and loading patterns of standard loading,manual and inverse optimization for intracavitary brachytherapy on a subset of tandem/ovoid cases[J].Radiother Oncol,2010,97:501-506.DOI:10.1016/j.radonc.2010.08.011.
[34]Lindegaard JC,Tanderup K,Nielsen SK,et al. MRI-guided 3D optimization significantly improves DVH parameters of Pulsed-Dose-Rate brachytherapy in locally advanced cervical cancer[J].Int J Radiat Oncol Biol Phys,2007,71(2):756-764.DOI:10.1016/j.ijrobp.2007.10.032.
[35]Kang HC,Shin KH,Park SY,et al.3D CT-based high-dose-rate brachytherapy for cervical cancer:clinical impact on late rectal bleeding and local control[J].Radiother Oncol J Eur Soc Ther Radiol Oncol,2010,97(2):507-513.DOI:10.1016/j.radonc.2010.10.002.
[36]Yang CF,Yang HM,Liang HQ,et al. Comparison of graphical optimization or IPSA for improving brachytheraphy plans associated with inadequate target coverage for cervical cancer[J].Scientific Reports,2017,7(1).DOI:10.1038/s41598-017-16756-w.
[37]Palmqvist T,Wanderas AD,Marthinsen ABL,et al. Dosimetric evaluation of manually and inversely optimized treatment planning for high dose rate brachytherapy of cervical cancer[J].Acta Oncol,2016,53(8):1012-1018.DOI:10.3109/0284186X.2014.928829.
[38]Tinkle CL,Weinberg V,Chen LM,et al. Inverse planned high-dose-rate brachytherapy for locoregionally advanced cervical cancer:4-year outcomes[J].Int J Radiat Oncol Biol Phys,2015,92(5):1093-1100.DOI:10.1016/j.ijrobp.2015.04.018.
[39]Van de Kamer JB., De Leeuw AA,Moerland MA,et al. Determining DVH parameters for combined external beam and brachytherapy treatment:3D biological dose adding for patients with cervical cancer[J].Radiother Oncol,2010,94(2):248-253.DOI:10.1016/j.radonc.2009.12.011.
[40]Fenkell L,Assenholt M,Nielsen SK,et al. Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer[J].Int J Radiat Oncol Biol Phys,2011,79(5):1572-1579.DOI:10.1016/j.ijrobp.2010.05.031.
[41]Kirchheiner K,Nout RA,Lindegaard JC,et al. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio (chemo) therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study[J].Radiother Oncol,2016,118(1):160-166.DOI:10.1016/j.radonc.2015.12.025.
[42]Tanderup K,Fokdal LU,Sturdza A,et al. Effect of tumor dose,volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer[J].Radiother Oncol,2016,120(3):441-446.DOI:10.1016/j.radonc.2016.05.014.
[43]施丹,赵志鹏,何明远,等.宫颈癌三维适形近距离治疗膀胱体积变化对正常组织受量影响[J].中华放射肿瘤学杂志,2015,24(2):159-162.DOI:10.3760/cma.j.issn.1004-4221.2015.02.013.
Shi D,Zhao ZP,He MY,et al. Effect of bladder volume change on normal tissue doses in external 3DRT and 3D conformal brachytherapy for cervical cancer[J].Chin J Radiat Oncol,2015,24(2):159-162.DOI:10.3760/cma.j.issn.1004-4221.2015.02.013.
[44]Jamema SV,Sharma S,Mahantshetty U,et al. Comparison of IPSA with dose-point optimization and manual optimization for interstitial template brachytherapy for gynecologic cancers[J].Brachytherapy,2011,10(4):306-312.DOI:10.1016/j.brachy.2010.08.011.
[45]Trnková P,Pátter R,Baltas D,et al. New inverse planning technology for image-guided cervical cancer brachytherapy:description and evaluation within a clinical frame.[J].Radiother Oncol,2009,93(2):331.DOI:10.1016/j.radonc.2009.10.004.